Css LLC Gossamer Bio, Inc. Call Options Transaction History

Css LLC

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2022 Nov 14, 2022	SELL	$7.21 - $14.88 $4,326 - $8,928	-600 Reduced 2.08%	28,200 $338,000
Q2 2022 Aug 15, 2022	BUY	$5.97 - $9.97 $171,936 - $287,136	28,800 New	28,800 $241,000
Q2 2020 Aug 14, 2020	SELL	$9.52 - $15.98 $260,848 - $437,852	-27,400 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$8.0 - $15.48 $214,400 - $414,864	26,800 Added 4466.67%	27,400 $277,000
Q4 2019 Feb 14, 2020	BUY	$14.82 - $26.79 $8,892 - $16,074	600 New	600 $9,000

108

167M

430K

519K

Ticker GOSS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 93,954,000
Market Cap $66.7M
Description
Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology in the United States. The company is developing GB002, an inhaled, small molecule, platelet-derived growth factor receptor, or PDGFR, colony...

Get notified when there are updates to the investment portfolio of Css LLC, based on Form 13F filings with the SEC.

Stay updated on Css LLC with notifications on news.